A session that covered safety and effects of exercise in recent onset and established adult and juvenile IIM. Dr....
EULAR/ACR Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major SubgroupsMyositis Support, , Featured, News
Clinical trials and studies require patient groups in clearly defined categories, but the multiple diagnostic and classification criteria used...
Today, Corbus Pharmaceuticals announced that the European Commission has approved orphan designation for lenabasum in the treatment of dermatomyositis...
"New Developments on the Role of Itch in Dermatomyositis", based on new research published in the British Journal of...
Investigators are seeking people with dermatomyositis to participate in a phase 2 clinical trial of the experimental drug IMO-8400....
- Join us for Rare Disease Day
- Browse Myositis Videos
- Explore Myositis
- Get Support
- Myositis Clinical Trials
- Myositis News
- Myositis Programs
- Upcoming Events
- Donate today!
February 25 @ 6:00 pm - 7:00 pm EST
February 28 @ 5:00 pm - 6:30 pm EST
February 29 @ 3:00 pm - 4:00 pm EST
Register to join “An Introduction to the PRESIDIO Clinical Trial of KZR-616 for the Treatment of Polymyositis and Dermatomyositis”February 29 @ 5:00 pm - 6:00 pm EST